Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

NCT04545554 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

DRUG: Romosozumab
DIETARY_SUPPLEMENT: Calcium
DIETARY_SUPPLEMENT: Vitamin D

Sponsor

Amgen